Media - published on 06 Mar 2017

Vaccins tegen ebola en malaria in de maak

Karel Berkhout covers the publication of the Access to Vaccines Index 2017, in particular referring to the development of new vaccines against ebola and malaria.

In the article, he writes : “After years of stagnation, many affordable vaccines for poor countries are in development. Pharmaceutical companies have gone a long way toward the development of vaccines for ebola and malaria, while the first vaccine for dengue has been approved.”


Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.